mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
3e-10 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
5e-08 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
4e-07 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
5e-07 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-06 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-06 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-06 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-06 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
3e-06 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
5e-06 |